Chloe Delepine

7PUBLICATIONS
73CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Nanoscale characterisationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 15, 2026
Transcriptomic profiling identifies immunotherapy-responsive phenotypes in microsatellite-stable metastatic colorectal cancer.

|Apr 14, 2026
Early differential impact of MeCP2 mutations on functional networks in Rett syndrome patient-derived human cortical organoids.

Tatsuya Osaki, Chloe Delepine, Yuma Osako

|Jan 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.

Breelyn A Wilky, Gary K Schwartz, Michael S Gordon

|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan

|Jun 13, 2024
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih

|Jul 29, 2022
Label-free three-photon imaging of intact human cerebral organoids for tracking early events in brain development and deficits in Rett syndrome.

Murat Yildirim, Chloe Delepine, Danielle Feldman

Pageof 2

Frequent Collaborators

3 joint publications

Joseph E Grossman

3 joint publications

Dhan Chand

3 joint publications

Justin Stebbing

2 joint publications

Vincent A Pham